Global COPD & Asthma Devices Market (2016-2022)

  • ID: 3951198
  • Report
  • Region: Global
  • 375 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 5

FEATURED COMPANIES

  • 3M Healthcare
  • AstraZeneca Plc
  • Baxter International
  • GF Health Products, Inc
  • Glaxosmithcline PLC
  • Koninklijke Philips N.V.
  • MORE
The global asthma and COPD drug market is a multi-billion dollar market which has a history of several decades and has witnessed number of technological advancements and product development over the past few years. Growing aging population coupled with increasing automotive and industrial exhaust gases have remained the key drivers for the global asthma and COPD market. Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies of China, India, Brazil and Russia. Increasing disposable income levels in emerging economies as well as developing countries of Latin America, Middle East & Africa has led to the increased usage of asthma pumps and sprays in these regions. However, the unknown etiology of asthma and COPD in medical industry may hamper the market growth in the next six years. Upcoming treatment methodologies such as once-a-day combination products and monoclonal antibodies have created new opportunities for the market growth. Additionally, pharmaceutical companies have been developing new bio-based medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for asthma & COPD market over the next decade.

The report highlights the adoption of COPD & Asthma Devices worldwide. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M Healthcare
  • AstraZeneca Plc
  • Baxter International
  • GF Health Products, Inc
  • Glaxosmithcline PLC
  • Koninklijke Philips N.V.
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global COPD & Asthma Devices, By Product Type
1.4.2 Global COPD & Asthma Devices Market, By Country
1.5 Research Methodology

2. GLOBAL COPD AND ASTHMA DEVICES MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.3 North America COPD & Asthma Device Market
2.4 Europe COPD & Asthma Device Market
2.5 Asia Pacific COPD & Asthma Device Market
2.6 LAMEA COPD & Asthma Device Market

3. Global COPD and Asthma Device Market - By Product Type
3.1 Global COPD & Asthma Inhaler Market
3.1.1 Global COPD & Asthma Inhaler Market - By Product Type
3.1.1.1 Global COPD & Asthma Dry Powder Inhalers (DPIs) Market - By Geography
3.1.1.1.1 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.2 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.3 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.4 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.2 Global COPD & Asthma Metered Dose Inhalers (MDIs) Market - By Geography
3.1.1.2.1 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.2 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.3 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.4 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.3 Global COPD & Asthma Soft Mist Inhalers (SMIs) Market - By Geography
3.1.1.3.1 North America COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.3.2 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.3.3 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.3.4 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2 Global COPD & Asthma Inhaler Market - By Geography
3.1.2.1 North America COPD & Asthma Inhaler Market
3.1.2.1.1 North America COPD & Asthma Inhaler Market - By Country
3.1.2.1.2 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.1.3 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.1.4 North America COPD & Asthma Soft Mist Inhalers (MDIs) Market
3.1.2.2 Europe COPD & Asthma Inhaler Market
3.1.2.2.1 Europe COPD & Asthma Inhaler Market - By Country
3.1.2.2.2 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.2.3 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.2.4 Europe COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2.3 Asia Pacific COPD & Asthma Inhaler Market
3.1.2.3.1 Asia Pacific COPD & Asthma Inhaler Market - By Country
3.1.2.3.2 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.3.3 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.3.4 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2.4 LAMEA COPD & Asthma Inhaler Market
3.1.2.4.1 LAMEA COPD & Asthma Inhaler Market - By Country
3.1.2.4.2 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.4.3 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.4.4 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.2 Global COPD & Asthma Nebulizer Market
3.2.1 Global COPD & Asthma Nebulizer Market - By Type
3.2.1.1 Global COPD & Asthma Pneumatic Nebulizers Market- By Geography
3.2.1.1.1 North America COPD & Asthma Pneumatic Nebulizers Market
3.2.1.1.2 Europe COPD & Asthma Pneumatic Nebulizer Market
3.2.1.1.3 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.2.1.1.4 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.1.2 Global COPD & Asthma Ultrasonic Nebulizer Market - By Geography
3.2.1.2.1 North America COPD & Asthma Ultrasonic Nebulizer Market - By Country
3.2.1.2.2 Europe COPD & Asthma Ultrasonic Nebulizer Market - By Country
3.2.1.2.3 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market - By Country
3.2.1.2.4 LAMEA COPD & Asthma Ultrasonic Nebulizer Market - By Country
3.2.1.3 Global COPD & Asthma Mesh Nebulizer Market - By Geography
3.2.1.3.1 North America COPD & Asthma Mesh Nebulizer Market- By Country
3.2.1.3.2 Europe COPD & Asthma Mesh Nebulizer Market - By Country
3.2.1.3.3 Asia Pacific COPD & Asthma Mesh Nebulizer Market - By Country
3.2.1.3.4 LAMEA COPD & Asthma Mesh Nebulizer Market - By Country
3.2.2 Global COPD & Asthma Nebulizer Market - By Geography
3.2.2.1 North America COPD & Asthma Nebulizer Market - By Type
3.2.2.2 North America COPD & Asthma Nebulizer Market - By Country
3.2.2.3 North America COPD & Asthma Pneumatic Nebulizer Market
3.2.2.4 North America COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.5 North America COPD & Asthma Mesh Nebulizer Market
3.2.2.6 Europe COPD & Asthma Nebulizer Market - By Product Type
3.2.2.6.1 Europe COPD & Asthma Nebulizer Market - By Country
3.2.2.6.2 Europe COPD & Asthma Pneumatic Nebulizer Market
3.2.2.6.3 Europe COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.6.4 Europe COPD & Asthma Mesh Nebulizer Market
3.2.2.7 Asia Pacific COPD & Asthma Nebulizer Market - By Product Type
3.2.2.7.1 Asia Pacific COPD & Asthma Nebulizer Market - By Country
3.2.2.7.2 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.2.2.7.3 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.7.4 Asia Pacific COPD & Asthma Mesh Nebulizer Market
3.2.2.8 LAMEA COPD & Asthma Nebulizer Market - By Product Type
3.2.2.8.1 LAMEA COPD & Asthma Nebulizer Market - By Country
3.2.2.8.2 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.2.8.3 LAMEA COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.8.4 LAMEA COPD & Asthma Mesh Nebulizer Market

4. Global COPD & Asthma Devices Market - By Geography
4.1 North America COPD & Asthma Device Market
4.1.1 U.S COPD and Asthma Devices Market
4.1.1.1 U.S COPD and Asthma Devices Market - By Product Type
4.1.1.1.1 U.S COPD and Asthma Inhalers Market
4.1.1.1.2 U.S COPD and Asthma Nebulizers Market
4.1.2 Canada COPD and Asthma Devices Market
4.1.2.1 Canada COPD and Asthma Devices Market - By Product Type
4.1.2.1.1 Canada COPD and Asthma Inhalers Market - By Product Type
4.1.2.1.2 Canada COPD and Asthma Nebulizers Market
4.1.3 Mexico COPD and Asthma Devices Market
4.1.3.1 Mexico COPD and Asthma Devices Market - By Product Type
4.1.3.1.1 Mexico COPD and Asthma Inhalers Market
4.1.3.1.2 Mexico COPD and Asthma Nebulizers Market - By Product Type
4.1.4 Rest of North America COPD and Asthma Devices Market
4.1.4.1 Rest of North America COPD and Asthma Devices Market - By Product Type
4.1.4.1.1 Rest of North America COPD and Asthma Inhalers Market
4.1.4.1.2 Rest of North America COPD and Asthma Nebulizers Market
4.2 Europe COPD & Asthma Device Market
4.2.1 Russia COPD and Asthma Devices Market
4.2.1.1 Russia COPD and Asthma Devices Market - By Product Type
4.2.1.1.1 Russia COPD and Asthma Inhalers Market - By Product Type
4.2.1.1.2 Russia COPD and Asthma Nebulizers Market
4.2.2 Germany COPD and Asthma Devices Market
4.2.2.1 Germany COPD and Asthma Devices Market - By Product Type
4.2.2.1.1 Germany COPD and Asthma Inhalers Market
4.2.2.1.2 Germany COPD and Asthma Nebulizers Market
4.2.3 UK COPD and Asthma Devices Market
4.2.3.1 UK COPD and Asthma Devices Market
4.2.3.1.1 UK COPD and Asthma Inhalers Market
4.2.3.1.2 UK COPD and Asthma Nebulizers Market
4.2.4 France COPD and Asthma Devices Market
4.2.4.1 France COPD and Asthma Devices Market - By Product Type
4.2.4.1.1 France COPD and Asthma Inhalers Market
4.2.4.1.2 France COPD and Asthma Nebulizers Market
4.2.5 Spain COPD and Asthma Devices Market
4.2.5.1 Spain COPD and Asthma Devices Market - By Product Type
4.2.5.1.1 Spain COPD and Asthma Inhalers Market
4.2.5.1.2 Spain COPD and Asthma Nebulizers Market
4.2.6 Italy COPD and Asthma Devices Market
4.2.6.1 Italy COPD and Asthma Devices Market - By Product Type
4.2.6.1.1 Italy COPD and Asthma Inhalers Market
4.2.6.1.2 Italy COPD and Asthma Nebulizers Market
4.2.7 Rest of Europe COPD and Asthma Devices Market
4.2.7.1 Rest of Europe COPD and Asthma Devices Market - By Product Type
4.2.7.1.1 Rest of Europe COPD and Asthma Inhalers Market
4.2.7.1.2 Rest of Europe COPD and Asthma Nebulizers Market
4.3 Asia Pacific COPD & Asthma Device Market
4.3.1 China COPD and Asthma Devices Market
4.3.1.1 China COPD and Asthma Devices Market - By Product Type
4.3.1.1.1 China COPD and Asthma Inhalers Market
4.3.1.1.2 China COPD and Asthma Nebulizers Market
4.3.2 Japan COPD and Asthma Devices Market
4.3.2.1 Japan COPD and Asthma Devices Market - By Product Type
4.3.2.1.1 Japan COPD and Asthma Inhalers Market
4.3.2.1.2 Japan COPD and Asthma Nebulizers Market
4.3.3 India COPD and Asthma Devices Market
4.3.3.1 India COPD and Asthma Inhalers Market - By Product Type
4.3.3.1.1 India COPD and Asthma Inhalers Market
4.3.3.1.2 India COPD and Asthma Nebulizers Market
4.3.4 South Korea COPD and Asthma Devices Market
4.3.4.1 South Korea COPD and Asthma Devices Market - By Product Type
4.3.4.1.1 South Korea COPD and Asthma Inhalers Market
4.3.4.1.2 South Korea COPD and Asthma Nebulizers Market
4.3.5 Australia COPD and Asthma Devices Market
4.3.5.1 Australia COPD and Asthma Devices Market - By Product Type
4.3.5.1.1 Australia COPD and Asthma Inhalers Market
4.3.5.1.2 Australia COPD and Asthma Nebulizers Market
4.3.6 Malaysia COPD and Asthma Devices Market
4.3.6.1 Malaysia COPD and Asthma Devices Market - By Product Type
4.3.6.1.1 Malaysia COPD and Asthma Inhalers Market
4.3.6.1.2 Malaysia COPD and Asthma Nebulizers Market
4.3.7 Rest of Asia Pacific COPD and Asthma Devices Market
4.3.7.1 Rest of Asia Pacific COPD and Asthma Devices Market - By Product Type
4.3.7.1.1 Rest of Asia Pacific COPD and Asthma Inhalers Market
4.3.7.1.2 Rest of Asia Pacific COPD and Asthma Nebulizers Market
4.4 LAMEA COPD & Asthma Device Market
4.4.1 Brazil COPD and Asthma Devices Market
4.4.1.1 Brazil COPD and Asthma Devices Market - By Product Type
4.4.1.1.1 Brazil COPD and Asthma Inhalers Market
4.4.1.1.2 Brazil COPD and Asthma Nebulizers Market
4.4.2 Argentina COPD and Asthma Devices Market
4.4.2.1 Argentina COPD and Asthma Devices Market - By Product Type
4.4.2.1.1 Argentina COPD and Asthma Inhalers Market
4.4.2.1.2 Argentina COPD and Asthma Nebulizers Market
4.4.3 UAE COPD and Asthma Devices Market
4.4.3.1 UAE COPD and Asthma Devices Market - By Product Type
4.4.3.1.1 UAE COPD and Asthma Inhalers Market
4.4.3.1.2 UAE COPD and Asthma Nebulizers Market
4.4.4 Saudi Arabia COPD and Asthma Devices Market
4.4.4.1 Saudi Arabia COPD and Asthma Devices Market - By Product Type
4.4.4.1.1 Saudi Arabia COPD and Asthma Inhalers Market
4.4.4.1.2 Saudi Arabia COPD and Asthma Nebulizers Market
4.4.5 South Africa COPD and Asthma Devices Market
4.4.5.1 South Africa COPD and Asthma Devices Market - By Product Type
4.4.5.1.1 South Africa COPD and Asthma Inhalers Market
4.4.5.1.2 South Africa COPD and Asthma Nebulizers Market
4.4.6 Nigeria COPD and Asthma Devices Market
4.4.6.1 Nigeria COPD and Asthma Devices Market - By Product Type
4.4.6.1.1 Nigeria COPD and Asthma Inhalers Market
4.4.6.1.2 Nigeria COPD and Asthma Nebulizers Market
4.4.7 Rest of LAMEA COPD and Asthma Devices Market
4.4.7.1 Rest of LAMEA COPD and Asthma Devices Market - By Product Type
4.4.7.1.1 Rest of LAMEA COPD and Asthma Inhalers Market
4.4.7.1.2 Rest of LAMEA COPD and Asthma Nebulizers Market

5. Company Profiles
5.1 Glaxosmithcline PLC
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental Analysis
5.1.4 Research & Development
5.2 Novartis International AG
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental Analysis
5.2.4 Research & Development
5.3 Merck & Co., Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental Analysis
5.3.4 Research & Development
5.4 AstraZeneca Plc
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental Analysis
5.4.4 Research & Development
5.5 3M Healthcare
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental Analysis
5.5.4 Research & Development
5.6 GF Health Products, Inc
5.6.1 Company Overview
5.7 Sunovion Pharmaceuticals Inc.
5.7.1 Company Overview
5.8 Smith Medicals, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.9 Baxter International
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental Analysis
5.9.4 Research & Development
5.1 Koninklijke Philips N.V.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental Analysis
5.10.4 Research & Development
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Glaxosmithcline PLC
- Novartis International AG
- Merck & Co., Inc.
- AstraZeneca Plc
- 3M Healthcare
- GF Health Products, Inc
- Sunovion Pharmaceuticals Inc.
- Koninklijke Philips N.V.
- Smith Medicals, Inc.
- Baxter International
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll